Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Read More Pharma Industry News CHMP recommends approval for BeiGene’s tislelizumab in ESCC treatment BeiGene, a global biotechnology firm, has revealed that the European Medicines Agency’s (EMA) Committee for Medicinal Products for… byPallavi MadhirajuJuly 22, 2023